Crocs (CROX) Soars Ahead of Investor Presentation
More News related to CROX
- Standpoint Research Initiates Coverage on Crocs (CROX) with a Buy
- Unusual 11 Mid-Day Movers 11/06: CBBO, OPTT, GROW, MGA Higher; GOK, OSTE, NHWK, OCLS Lower
- Morning Movers 11/06: ACLS, CVM, ZIOP, LPSN, CABL, ZGEN Higher; NHWK, GOK, CROX, CVI, RAIL, CSTR Lower
- Piper Jaffray Maintains an 'Overweight' Rating on Crocs (CROX); Channel Diversity Providing Topline Hedge
- After-Hours Movers 11/05: JSDA, ENOC, SAM, RST, ASEI, KFN Higher; MOVE, FNM, CROX, BEBE, BID Lower
More News related to Insiders' Blog
- Kinross Gold (KGC) Receives Authorization to Re-Commence Exploration on Project in Ecuador
- Sanofi-aventis (SNY) and Regeneron Pharmaceuticals (REGN) to Expand Global Collaboration
- Stryker (SYK) Announces Two Acquisitions
- Adobe (ADBE) Cutting 680 Full-Time Jobs to Align Costs with '10 Operating Plan
- Teva Pharma (TEVA) Gets Final U.S. FDA Approval for Generic Prevacid
Shares of Crocs (Nasdaq: CROX) are seeing interest today ahead of a presentation at the Piper Jaffray Consumer Conference in New York today. The company is scheduled to present at 12:30PM ET.
Shares of CROX are up 16% on heavier-than-normal volume ahead of the event.
Crocs, Inc. and its subsidiaries design, develop, and manufacture consumer products from specialty resins worldwide.
Real-Time Market Moving News Two-Weeks FREE http://www.streetinsider.com/premium_content.php
Related Categories
Insiders' BlogMomentum Movers
Trader Talk
Stocks Mentioned
-0.10Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
